Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.27 | -18.91 |
| PEG Ratio (TTM) | 1.03 | -6.31 |
| P/S Ratio (TTM) | 0.50 | 43.95 |
| P/B Ratio (TTM) | 0.16 | 29.39 |
| P/FCF Ratio (TTM) | -0.37 | -3.28 |
| Price to 5YR AVG Earnings Ratio | -0.10 | -6.21 |
| Price to 5YR AVG FCF Ratio | -0.61 | -11.60 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -52.24% | -12.67% |
| ROE (TTM) | -50.08% | 28.89% |
| Net Profit Margin (TTM) | -180.22% | -732.84% |
| ROIC 5YR AVG | -34.36% | -1.18% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.09% | -42.80% | -98.92% |
| Revenue | 89.38% | -55.95% | -33.57% |
| Net Income | -13.82% | -164.41% | -182.00% |
| Cash Flow | -108.06% | -36.02% | -55.67% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 10.25 | 5.49 |
| Quick Ratio (TTM) | 10.25 | 5.27 |
| D/E Ratio (TTM) | N/A | 1.02 |
| Interest Coverage (TTM) | -202.56 | -4.57 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | N/A | 12.42 |
| LTL to 5YR AVG FCF | -0.30 | 0.12 |
| Shares Outstanding Growth 5YR AVG | 250.37% | 37.88% |